Chemfab Alkalis Ltd
NSE: CHEMFAB BSE: 541269
Incorproated in 2009, Chemfab Alkalis Ltd manufactures basic inorganic chemicals and PVCO pipes[1]
₹437
52W: ₹270 — ₹880
PE 83.6 · Book ₹288 · +52% vs bookMarket Cap₹628 Cr
Stock P/E83.6Price to Earnings
ROCE3.54%Return on Capital
ROE1.83%Return on Equity
Div. Yield0.29%Face Value ₹10
Weaknesses
- −The company has delivered a poor sales growth of 9.80% over past five years.
- −Company has a low return on equity of 4.38% over last 3 years.
- −Dividend payout has been low at 13.9% of profits over last 3 years
Shareholding Pattern
Promoters72.14%
FIIs0.04%
DIIs0.1%
Public27.64%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.88% | 72.63%▼0.3 | 72.56%▼0.1 | 72.18%▼0.4 | 72.18% | 72.18% | 72.14%▼0.0 | 72.14% |
| FIIs | 0.27% | 0.11%▼0.2 | 0.03%▼0.1 | 0.03% | 0.01%▼0.0 | 0%▼0.0 | 0.08%▲0.1 | 0.04%▼0.0 |
| DIIs | 0.07% | 0.07% | 0.27%▲0.2 | 0.27% | 0.27% | 0.27% | 0.22%▼0.1 | 0.1%▼0.1 |
| Public | 26.77% | 27.2%▲0.4 | 27.12%▼0.1 | 27.5%▲0.4 | 27.53%▲0.0 | 27.48%▼0.1 | 27.49%▲0.0 | 27.64%▲0.2 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 86.33 | 82.3 | 76.04 | 79 | 79.21 | 87.85 | 87.58 | 70.41 | 61.85 | 68.73 |
| Expenses | 69.94 | 69.13 | 65.59 | 66.34 | 64.72 | 72.16 | 74.16 | 61.97 | 56.68 | 61.36 |
| Operating Profit | 16.39 | 13.17 | 10.45 | 12.66 | 14.49 | 15.69 | 13.42 | 8.44 | 5.17 | 7.37 |
| OPM % | 18.99% | 16% | 13.74% | 16.03% | 18.29% | 17.86% | 15.32% | 11.99% | 8.36% | 10.72% |
| Net Profit | 8.16 | 6.56 | 4.33 | 2.95 | 4.02 | 3.93 | 5.39 | 1.59 | -1.04 | 1.56 |
| EPS ₹ | 5.74 | 4.61 | 3.03 | 2.06 | 2.81 | 2.74 | 3.75 | 1.11 | -0.72 | 1.09 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹289Cr, down 10.2% YoY. OPM at 12%.
Debt Position
Borrowings at ₹126Cr. Debt-to-equity ratio: 0.32x. Healthy balance sheet.
Capex Cycle
CWIP at ₹28Cr (9% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.1% (+0.03pp change). FIIs: 0.04% (-0.24pp change). Promoters hold 72.14%.
Margin & Efficiency
ROCE improving from 0% (Mar 2015) to 4% (Mar 2026). Working capital days: -39.
Valuation
PE 83.6x with 3.54% ROCE. Price is 52% above book value of ₹288. Dividend yield: 0.29%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - Submission of newspaper clipping of Audited standalone and consolidated financial results for the quarter and financial year ended 31st March, 2026 approved by the Board …
- Submission Of Investor Presentation 14 May - Submission of investor presentation for the quarter and financial year ended 31st March 2026
- Announcement under Regulation 30 (LODR)-Change in Management 13 May - Board approved FY26 audited results, recommended Rs.1.25 final dividend, and appointed internal and cost auditors.
- Declaration With Respect To The Audit Report With Unmodified Opinion To The Audited Financial Results For The Financial Year Ended 31St March 2026 13 May - Board approved FY26 audited results, recommended Rs1.25 final dividend, and appointed auditors for FY27.
- Corporate Action-Board approves Dividend 13 May - Board approved FY26 audited results, recommended Rs1.25 final dividend, and appointed internal and cost auditors.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse